Biography

Dr. Todd Brothers, PharmD, BCCCP, BCPS, is a Clinical Associate Professor of Pharmacy Practice and Clinical Research at the University of Rhode Island College of Pharmacy. He is a licensed pharmacist and board-certified in both Critical Care (BCCCP) and Pharmacotherapy (BCPS), with additional certification in pharmacogenomics. His professional background spans over two decades of clinical practice, education, and research in acute and critical care settings.

Clinically, Dr. Brothers maintains an active practice in adult critical care at Roger Williams Medical Center, where he contributes to antimicrobial stewardship, medication safety, and interdisciplinary ICU care. His clinical work emphasizes optimizing pharmacotherapy in complex, high-acuity patients and improving patient-centered outcomes.

In his academic role, Dr. Brothers is a dedicated educator and mentor. He serves as Course Coordinator for Clinical & Therapeutic Sciences (PHP 527), Co-Coordinator for Precision Medicine and Applied Pharmacogenomics (BPS/PHP 547), and a preceptor for advanced pharmacy practice experiences in critical care. He teaches across PharmD, graduate, and interprofessional programs and is widely recognized for his engaging, clinically grounded teaching style. In recognition of his contributions to education, he was named the 2025 University of Rhode Island College of Pharmacy Faculty of the Year.

Dr. Brothers is actively engaged in professional and institutional service. He serves as Co-Chair of the Rhode Island Medicaid Pharmacy and Therapeutics Committee and as an Executive Council Member of the Rhode Island Pharmacists Association, contributing to statewide policy, formulary decision-making, and advancement of pharmacy practice.

His research lies at the intersection of critical care pharmacotherapy, chronic kidney disease (CKD), and artificial intelligence–driven precision medicine. He focuses on leveraging large-scale electronic health record (EHR) data, machine learning, and synthetic data to identify clinically meaningful patient subgroups, predict disease progression, and optimize medication-related outcomes. He serves as Co-Principal Investigator on the ACCP Foundation–funded OPTOCS-AI project, which aims to optimize pharmacy-led transitions of care using artificial intelligence, and contributes to an NIH/NHLBI R21 proposal developing an AI-driven dashboard for heart failure transitions of care.